Advertisement
UK markets open in 1 hour 1 minute
  • NIKKEI 225

    39,182.39
    +377.74 (+0.97%)
     
  • HANG SENG

    18,122.99
    +95.28 (+0.53%)
     
  • CRUDE OIL

    81.66
    +0.03 (+0.04%)
     
  • GOLD FUTURES

    2,337.40
    -7.00 (-0.30%)
     
  • DOW

    39,411.21
    +260.91 (+0.67%)
     
  • Bitcoin GBP

    48,085.49
    -978.19 (-1.99%)
     
  • CMC Crypto 200

    1,269.58
    -40.13 (-3.06%)
     
  • NASDAQ Composite

    17,496.82
    -192.54 (-1.09%)
     
  • UK FTSE All Share

    4,514.76
    +23.84 (+0.53%)
     

embecta to Participate in Investor Events

Embecta Corp.
Embecta Corp.

PARSIPPANY, N.J., May 01, 2024 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta”) (Nasdaq: EMBC), a global diabetes care company with a 100-year legacy in insulin delivery, today announced that management will participate in the following investor events:

2024 BofA Securities Healthcare Conference

  • Management will host a fireside session on Thursday, May 16, 2024, at 10:00 a.m. Pacific Time (PT) at the Encore Hotel in Las Vegas. Audio webcasts of the presentations will be accessible under the “News & Events” section of the Company's investor relations website at https://investors.embecta.com.

2024 Jefferies Global Healthcare Conference

ADVERTISEMENT
  • Management will host a fireside session on Wednesday, June 5, 2024, at 5:30 p.m. Eastern Time (ET) at the Marriott Marquis in New York. Audio webcasts of the presentations will be accessible under the “News & Events” section of the Company's investor relations website at https://investors.embecta.com.

2024 Truist Securities MedTech Conference

  • Management will host one-on-one investor meetings on Tuesday, June 18, 2024, at the InterContinental Hotel in Boston.

2024 Stifel’s Inaugural ADA Diabetes Tech Summit

  • Management will host a fireside session on Friday, June 21, 2024, in Orlando.

About embecta 

embecta is one of the largest pure-play diabetes care companies in the world, leveraging its nearly 100-year legacy in insulin delivery to empower people with diabetes to live their best life through innovative solutions, partnerships and the passion of approximately 2,000 employees around the globe. For more information, visit embecta.com or follow our social channels on LinkedIn, Facebook, Instagram and Twitter.

Contacts:

Media

Investors

Christian Glazar

Pravesh Khandelwal

Sr. Director, Corporate Communications

VP, Head of Investor Relations

908-821-6922

551-264-6547

Contact Media Relations

Contact IR